Newly Funded Health Records Database Will Boost Japan's Pharmacovigilance
This article was originally published in The Pink Sheet Daily
Executive Summary
Japanese Ministry of Health, Labor and Welfare had to rely on EU and U.S. regulators for Actos safety data concerning bladder cancer risk.
You may also be interested in...
EU's CHMP Delays Decision On Actos, Restricts Use Of An NSAID And Cytoprotective
Europe's top regulatory advisory panel wants further analysis of Actos' link with bladder cancer, but recommends limiting indications for the NSAID nimesulide and adding contraindications for the cytoprotective dexrazoxane.
Japan To Pass Bill For Special Economic Zones To Boost Foreign Investment And Consumer Confidence
TOKYO - Japan's Diet will pass legislation June 20 to create special economic zones in Northern Japan as part of the reconstruction effort from the March 11 earthquake and ensuing tsunami and nuclear crisis. While the specifics for the economic zones have yet to be settled, it is expected that substantial tax breaks will be included in the incentives to encourage reconstruction and foreign investment
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.